Glycemia and Ischemia Reperfusion Brain Injury in Patients With Acute Cerebral Infarction Treated With Mechanical Thrombectomy
Cerebral Infarction
About this trial
This is an interventional health services research trial for Cerebral Infarction
Eligibility Criteria
Inclusion Criteria: Men and women over 18 years of age Neuroimaging studies such as computed tomography (CT), angio-CT or angio-MRI compatible with the diagnosis of acute cerebral infarction due to occlusion of a large vessel of the anterior circulation, including the internal carotid artery (intra- or extracranial) or middle cerebral artery (M1 or M2 segments). Indication of mechanical thrombectomy according to clinical practice. Inclusion of the patient in the study before the endovascular procedure. Modified Rankin Scale (mRS) score prior to stroke of 0-1. Signature of informed consent. Exclusion Criteria: CT, angio-CT or angio-MRI showing posterior circulation occlusion. Severe or life-threatening concomitant disease that precludes follow-up for 3 months after stroke, Alcohol or drug abuse Participation in a therapeutic clinical trial.
Sites / Locations
- Hospital Universitario La PazRecruiting
Arms of the Study
Arm 1
Experimental
Subcutaneous blood glucose monitoring device
After signing the informed consent and before the start of the endovascular procedure, a subcutaneous blood glucose monitoring device will be implanted, which will be removed on day 15 (or at hospital discharge if this takes place before 15 days).